247 related articles for article (PubMed ID: 30947731)
1. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.
Xiang Y; Wang Q; Guo Y; Ge H; Fu Y; Wang X; Tao L
J Exp Clin Cancer Res; 2019 Apr; 38(1):145. PubMed ID: 30947731
[TBL] [Abstract][Full Text] [Related]
2. Connexin32 activates necroptosis through Src-mediated inhibition of caspase 8 in hepatocellular carcinoma.
Xiang YK; Peng FH; Guo YQ; Ge H; Cai SY; Fan LX; Peng YX; Wen H; Wang Q; Tao L
Cancer Sci; 2021 Sep; 112(9):3507-3519. PubMed ID: 34050696
[TBL] [Abstract][Full Text] [Related]
3. Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways.
Zhao B; Zhao W; Wang Y; Xu Y; Xu J; Tang K; Zhang S; Yin Z; Wu Q; Wang X
Oncotarget; 2015 Apr; 6(12):10116-33. PubMed ID: 25426556
[TBL] [Abstract][Full Text] [Related]
4. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling.
Su Y; Meng L; Ge C; Liu Y; Zhang C; Yang Y; Tian W; Tian H
J Exp Clin Cancer Res; 2024 May; 43(1):142. PubMed ID: 38745188
[TBL] [Abstract][Full Text] [Related]
5. Connexin 32 affects doxorubicin resistance in hepatocellular carcinoma cells mediated by Src/FAK signaling pathway.
Yu M; Zou Q; Wu X; Han G; Tong X
Biomed Pharmacother; 2017 Nov; 95():1844-1852. PubMed ID: 28968929
[TBL] [Abstract][Full Text] [Related]
6. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
7. Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma.
Yang Y; Zhang N; Zhu J; Hong XT; Liu H; Ou YR; Su F; Wang R; Li YM; Wu Q
Int J Oncol; 2017 Jun; 50(6):1977-1988. PubMed ID: 28498415
[TBL] [Abstract][Full Text] [Related]
8. Impaired gap junctions in human hepatocellular carcinoma limit intrinsic oxaliplatin chemosensitivity: A key role of connexin 26.
Yang Y; Zhu J; Zhang N; Zhao Y; Li WY; Zhao FY; Ou YR; Qin SK; Wu Q
Int J Oncol; 2016 Feb; 48(2):703-13. PubMed ID: 26648344
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
10. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
Yin Y; Sun M; Zhan X; Wu C; Geng P; Sun X; Wu Y; Zhang S; Qin J; Zhuang Z; Liu Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):83. PubMed ID: 30770740
[TBL] [Abstract][Full Text] [Related]
11. Connexin32 regulates expansion of liver cancer stem cells via the PI3K/Akt signaling pathway.
Li H; Wang B; Qi B; Jiang G; Qin M; Yu M
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35894130
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
13. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
14. Cx32 inhibits TNFα-induced extrinsic apoptosis with and without EGFR suppression.
Lai Y; Tao L; Zhao Y; Zhang X; Sun X; Wang Q; Xu C
Oncol Rep; 2017 Nov; 38(5):2885-2892. PubMed ID: 28901517
[TBL] [Abstract][Full Text] [Related]
15. Non-junctional Cx32 mediates anti-apoptotic and pro-tumor effects via epidermal growth factor receptor in human cervical cancer cells.
Zhao Y; Lai Y; Ge H; Guo Y; Feng X; Song J; Wang Q; Fan L; Peng Y; Cao M; Harris AL; Wang X; Tao L
Cell Death Dis; 2017 May; 8(5):e2773. PubMed ID: 28492539
[TBL] [Abstract][Full Text] [Related]
16. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
[TBL] [Abstract][Full Text] [Related]
17. Connexin32‑mediated antitumor effects of suicide gene therapy against hepatocellular carcinoma: In vitro and in vivo anticancer activity.
Wu L; Zhou WB; Shen F; Liu W; Wu HW; Zhou SJ; Li SW
Mol Med Rep; 2016 Apr; 13(4):3213-9. PubMed ID: 26935255
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
20. The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M.
Zhao S; Li H; Wang Q; Su C; Wang G; Song H; Zhao L; Luan Z; Su R
BMC Cancer; 2015 May; 15():389. PubMed ID: 25958313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]